[The use of intravenous immunoglobulins in patients with severe burns].
The parenteral use of whole molecule immunoglobulins is an important instrument for immunotherapy which can be employed in a variety of morbid conditions characterized by immunodeficiency, and therefore also in the management of severe burns. In order to confirm this assumption, the effect of i.v. administration of immunoglobulins has been studied in a group of burn patients and has been compared with the results obtained in the same number of clinically homologous patients not submitted to this treatment. In view of the results obtained, i.v. immunoglobulins can be usefully employed for the control of inflammatory and septic phenomena with reduction of abnormal parameters and a positive influence on the recovery curve.
Mian
E U
EU
Clinica Dermatologica dell'Università di Pisa.
Gianfaldoni
R
R
Mian
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D002056:Burns / Q000628:therapy*; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index; D016896:Treatment Outcome
D016756:Immunoglobulins, Intravenous
Uso endovenoso delle immunoglobuline nell'ustionato grave.